{"id":"W3190815019","doi":"10.1097/coc.0000000000000856","title":"Prognostic Significance of Disease Control at 12 Weeks in Patients With Advanced Pancreatic Cancer Receiving FOLFIRINOX as First-line Chemotherapy","year":2021,"lang":"en","type":"article","venue":"American Journal of Clinical Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"FOLFIRINOX; Medicine; Hazard ratio; Internal medicine; Interquartile range; Confidence interval; Oncology; Pancreatic cancer; Progression-free survival; Olaparib; Chemotherapy; Gastroenterology; Surgery; Cancer; Irinotecan","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003153338,0.0001296385,0.0001966505,0.0003747649,0.0002488994,0.0004830203,0.0002803427,0.0002690415,0.0008244755],"category_scores_gemma":[0.001552739,0.00007520925,0.0001819529,0.0006209246,0.0002313138,0.000163572,0.0001570196,0.0003937169,0.00007626042],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009634895,"about_ca_system_score_gemma":0.0007050518,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03312923,"about_ca_topic_score_gemma":0.04524033,"domain_scores_codex":[0.9998382,0.00002487716,0.00001495707,0.00003055497,0.00004861032,0.00004276407],"domain_scores_gemma":[0.998394,0.0002206831,0.0007764921,0.00004500353,0.0001572738,0.0004066202],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000280552,0.00001880616,0.9980009,0.000004617257,0.00001765553,0.00004314534,0.00001754352,0.00007421776,0.000132109,0.000004202044,0.00007182718,0.001334406],"study_design_scores_gemma":[0.00001226932,0.00008273499,0.9993804,0.000003472218,0.00001278022,0.0001549891,0.0000352943,0.0001551596,0.00004765414,0.000004741322,0.0001087288,0.000001869893],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9991714,0.0003946238,0.00001762724,0.00004737518,0.000003297858,0.000003302768,0.0001432754,0.000002410492,0.0002167049],"genre_scores_gemma":[0.9997241,0.00005645688,0.0000174103,0.000009122608,0.000003576439,0.000001139603,0.0001328777,4.351111e-7,0.00005489618],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03312923,"threshold_uncertainty_score":0.06587279,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02854541636047952,"score_gpt":0.3923611423485976,"score_spread":0.3638157259881181,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}